Esranur Aydın @AydinEsranurr

Joined August 2022

Tweets

0
Followers

3
Following

32
Likes

2

No recent Tweets. New Tweets will appear here.

Prof.Dr.Mutlu Demiray @eceyrem

655 Followers 476 Following Dad of three daughters, Tumor Agnostic Medical Oncologist, Personalized Cancer Therapy Specialist

Ünal Metin Tokat @umtokat

113 Followers 945 Following 13.gezegende 1 yabancı

Şevval Nur Bilgiç @_sevbil

76 Followers 124 Following Koc University, PhD ITU MBG

Ünal Metin Tokat @umtokat

113 Followers 945 Following 13.gezegende 1 yabancı

FabriceAndre @FAndreMD

14K Followers 518 Following Head of Research Division of @GustaveRoussy , @myesmo President Elect

Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.

ASCO @ASCO

147K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.

İç Hastalıkları ve Tıbbi Onkoloji Uzmanı

Mutlu Demiray Kişiye Özel Kanser Tedavi Merkezi Kurucusu

Akıllı İlaç I Vitamin C I Hipertermi I İmmunoterapi

Prof. Dr. Mutlu Demir.. @MutluDemiray

2K Followers 112 Following İç Hastalıkları ve Tıbbi Onkoloji Uzmanı Mutlu Demiray Kişiye Özel Kanser Tedavi Merkezi Kurucusu Akıllı İlaç I Vitamin C I Hipertermi I İmmunoterapi

Director Medical&Precision Oncology #precisiononcology #liquidbx #hnc #LCSM @DanaFarber @ColumbiaMed @JIPOEditors @IylonOncology @rfhospital #IMPACTIndia

Sewanti Limaye 🇮�.. @SewantiLimaye

3K Followers 2K Following Director Medical&Precision Oncology #precisiononcology #liquidbx #hnc #LCSM @DanaFarber @ColumbiaMed @JIPOEditors @IylonOncology @rfhospital #IMPACTIndia

Vivek Subbiah, MD @VivekSubbiah

34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.

Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine

Razelle Kurzrock, MD @Dr_R_Kurzrock

7K Followers 5K Following Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine

MSK's precision oncology knowledge base w/ information about the effects & clinical implications of individual cancer gene alterations. Partially FDA-recognized

OncoKB™ @OncoKB

1K Followers 0 Following MSK's precision oncology knowledge base w/ information about the effects & clinical implications of individual cancer gene alterations. Partially FDA-recognized

The leading family of journals in gene & cell therapy. Journals include Molecular Therapy, Methods & Clinical Developments, Nucleic Acids, and Oncolytics.

Molecular Therapy @MolTherapy

3K Followers 366 Following The leading family of journals in gene & cell therapy. Journals include Molecular Therapy, Methods & Clinical Developments, Nucleic Acids, and Oncolytics.

An online resource for the latest cell therapy, gene therapy and regenerative medicine news. Part of the @STEMCELLTech Science News service.

Cell Therapy News @celltherapynews

12K Followers 502 Following An online resource for the latest cell therapy, gene therapy and regenerative medicine news. Part of the @STEMCELLTech Science News service.

Precision Medicine Fo.. @precisionforum

3K Followers 4K Following The organiser of Nordic 2024 #Digitalhealth #Data #AI #Precisionmedicine https://t.co/wU8gQ7kf0L

The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm

VJ Oncology @VJOncology

27K Followers 3K Following The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm

Latest research in oncology | Breaking news, insights, interviews, live tweeting and updates from major conferences | Published by @ilpensiero | @think2it

Oncoinfo @Oncoinfo_it

6K Followers 4K Following Latest research in oncology | Breaking news, insights, interviews, live tweeting and updates from major conferences | Published by @ilpensiero | @think2it

Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.

Medicine Matters onco.. @MM_Oncology

2K Followers 735 Following Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.

The leading independent source for information on the issues that shape #oncology since 1973. Editor: @PaulBGoldberg | Historical initiative: @cancerhistproj

The Cancer Letter @TheCancerLetter

26K Followers 2K Following The leading independent source for information on the issues that shape #oncology since 1973. Editor: @PaulBGoldberg | Historical initiative: @cancerhistproj

An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)

ACS Journal Cancer @JournalCancer

30K Followers 5K Following An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)

Journal of the National Cancer Institute (JNCI) & JNCI Cancer Spectrum publish peer-reviewed #research on #cancer and #oncology. @OUPAcademic journals.

JNCI @JNCI_Now

25K Followers 3K Following Journal of the National Cancer Institute (JNCI) & JNCI Cancer Spectrum publish peer-reviewed #research on #cancer and #oncology. @OUPAcademic journals.

Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/CbqH4ibXAn

Pfizer Oncology Medic.. @PfizerOncMed

34K Followers 2K Following Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/CbqH4ibXAn

Online Tumor Board with a molecular angle ~ Join us every Tuesday 8pm ET for discussions, polls, & mini tweetorials • Created by @MPishvaian • FREE CME

#TumorBoardTuesday @TumorBoardTues

5K Followers 1K Following Online Tumor Board with a molecular angle ~ Join us every Tuesday 8pm ET for discussions, polls, & mini tweetorials • Created by @MPishvaian • FREE CME

@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.

Journal of Clinical O.. @JCO_ASCO

50K Followers 1K Following @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.

Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology

Oncology Times @OncologyTimes

53K Followers 8K Following Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology

The latest science news stories, science current events, scientific research and discoveries in #biology, #molecularbiology, #lifescience, #health, #oncology.

Research feeds 🔬 @FeedsResearch

1K Followers 5K Following The latest science news stories, science current events, scientific research and discoveries in #biology, #molecularbiology, #lifescience, #health, #oncology.

PubMed/PubMed Central/Scopus/EMbase/Web of Science (ESCI) indexed, JCR Impact Factor 2022: 5.2.
Editor-in-Chief: Prof. Kazuaki Takabe, New York, USA

World Journal of Onco.. @WJON_Journal

3K Followers 707 Following PubMed/PubMed Central/Scopus/EMbase/Web of Science (ESCI) indexed, JCR Impact Factor 2022: 5.2. Editor-in-Chief: Prof. Kazuaki Takabe, New York, USA

Medscape Oncology @MedscapeOnc

40K Followers 533 Following Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.

The Best of ASCO Meetings offer timely science and education from the world’s premier oncology event, the ASCO Annual Meeting, in a two-day program.

Best of Oncology @bestofoncology

494 Followers 2K Following The Best of ASCO Meetings offer timely science and education from the world’s premier oncology event, the ASCO Annual Meeting, in a two-day program.

Weekly MTB (Precision.. @mtboftheweek

78 Followers 242 Following From peers for peers - weekly #PrecisionOncology cases discussed here. Tweets are not medical advice.

The Nobel Prize @NobelPrize

1.1M Followers 508 Following The official Twitter feed of the Nobel Prize @NobelPrize #NobelPrize

Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.

Annals of Oncology @Annals_Oncology

47K Followers 520 Following Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.

The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.

ESMO - Eur. Oncology @myESMO

75K Followers 873 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.

Prof.Dr.Mutlu Demiray @eceyrem

655 Followers 476 Following Dad of three daughters, Tumor Agnostic Medical Oncologist, Personalized Cancer Therapy Specialist

OncoDaily @oncodaily

a week ago

We delve into a captivating case showcasing the power of personalized and precision-oriented therapies in advanced cholangiocarcinoma management - Esranur Aydın @MedicanaSaglik @Sage_Publishing @Dr_R_Kurzrock @eceyrem oncodaily.com/55261.html #Cancer #OncoDaily #Oncology

0 4 28 7K 2

Download Image

0 0 1 19 0

Prof.Dr.Mutlu Demiray @eceyrem

7 days ago

"Amidst the ever-evolving landscape of cancer treatment, precision oncology stands as a beacon of hope, offering tailored solutions that target the unique genetic makeup of each patient's tumor. Our recent paper underscore the pressing need for such personalized approaches.…